Jiro Ikeda

534 total citations
14 papers, 404 citations indexed

About

Jiro Ikeda is a scholar working on Molecular Biology, Cancer Research and Neurology. According to data from OpenAlex, Jiro Ikeda has authored 14 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Neurology. Recurrent topics in Jiro Ikeda's work include Cancer, Hypoxia, and Metabolism (4 papers), Vagus Nerve Stimulation Research (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Jiro Ikeda is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Vagus Nerve Stimulation Research (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Jiro Ikeda collaborates with scholars based in Japan, Sweden and Canada. Jiro Ikeda's co-authors include Kenji Sunagawa, Toshihiro Ichiki, Hirohide Matsuura, Ryohei Miyazaki, Kotaro Takeda, Shiro Kitamoto, Tomotake Tokunou, Toru Hashimoto, Toru Hashimoto and Keita Inanaga and has published in prestigious journals such as Circulation, PLoS ONE and Hypertension.

In The Last Decade

Jiro Ikeda

14 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiro Ikeda Japan 11 169 142 85 75 62 14 404
Elke Marsch Netherlands 7 205 1.2× 160 1.1× 109 1.3× 67 0.9× 46 0.7× 8 492
Shujian Wei China 11 183 1.1× 88 0.6× 62 0.7× 77 1.0× 86 1.4× 22 488
Guomin Xie China 13 223 1.3× 79 0.6× 69 0.8× 68 0.9× 44 0.7× 26 480
Weili Xue China 12 282 1.7× 122 0.9× 90 1.1× 56 0.7× 51 0.8× 23 557
Melroy Miranda Switzerland 7 243 1.4× 168 1.2× 52 0.6× 112 1.5× 52 0.8× 10 586
Boquan Wu China 13 357 2.1× 107 0.8× 64 0.8× 50 0.7× 60 1.0× 23 548
Robert S. Fenning United States 8 200 1.2× 103 0.7× 96 1.1× 59 0.8× 68 1.1× 13 503
Shengkai Zuo China 16 279 1.7× 75 0.5× 116 1.4× 55 0.7× 124 2.0× 30 613
Weihua Wu China 11 333 2.0× 115 0.8× 69 0.8× 36 0.5× 66 1.1× 20 498
Filippo Zeni Italy 5 169 1.0× 113 0.8× 77 0.9× 77 1.0× 40 0.6× 7 423

Countries citing papers authored by Jiro Ikeda

Since Specialization
Citations

This map shows the geographic impact of Jiro Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiro Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiro Ikeda more than expected).

Fields of papers citing papers by Jiro Ikeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiro Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiro Ikeda. The network helps show where Jiro Ikeda may publish in the future.

Co-authorship network of co-authors of Jiro Ikeda

This figure shows the co-authorship network connecting the top 25 collaborators of Jiro Ikeda. A scholar is included among the top collaborators of Jiro Ikeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiro Ikeda. Jiro Ikeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Jongstra‐Bilen, Jenny, Kelly Tai, Marwan G. Althagafi, et al.. (2021). Role of myeloid-derived chemokine CCL5/RANTES at an early stage of atherosclerosis. Journal of Molecular and Cellular Cardiology. 156. 69–78. 23 indexed citations
2.
Ghaffari, Siavash, Changsen Wang, Benjamin E. Steinberg, et al.. (2020). Endothelial HMGB1 Is a Critical Regulator of LDL Transcytosis via an SREBP2–SR-BI Axis. Arteriosclerosis Thrombosis and Vascular Biology. 41(1). 200–216. 31 indexed citations
3.
Watanabe, Aya, Toshihiro Ichiki, Hiroshi Kojima, et al.. (2015). Suppression of abdominal aortic aneurysm formation by AR-R17779, an agonist for the α7 nicotinic acetylcholine receptor. Atherosclerosis. 244. 113–120. 8 indexed citations
4.
Ikeda, Jiro, Toshihiro Ichiki, Hiroshi Kojima, et al.. (2015). PPARγ Agonists Attenuate Palmitate-Induced ER Stress through Up-Regulation of SCD-1 in Macrophages. PLoS ONE. 10(6). e0128546–e0128546. 45 indexed citations
5.
Hashimoto, Toru, Toshihiro Ichiki, Aya Watanabe, et al.. (2014). Stimulation of α7 nicotinic acetylcholine receptor by AR-R17779 suppresses atherosclerosis and aortic aneurysm formation in apolipoprotein E-deficient mice. Vascular Pharmacology. 61(2-3). 49–55. 35 indexed citations
6.
Matsuura, Hirohide, Toshihiro Ichiki, Masatoshi Nomura, et al.. (2013). Prolyl Hydroxylase Domain Protein 2 Plays a Critical Role in Diet-Induced Obesity and Glucose Intolerance. Circulation. 127(21). 2078–2087. 60 indexed citations
7.
Ikeda, Jiro, Toshihiro Ichiki, Hirohide Matsuura, et al.. (2013). Deletion of Phd2 in Myeloid Lineage Attenuates Hypertensive Cardiovascular Remodeling. Journal of the American Heart Association. 2(3). e000178–e000178. 30 indexed citations
8.
Watanabe, Aya, Toshihiro Ichiki, Jiro Ikeda, et al.. (2013). Suppression of abdominal aortic aneurysm formation by inhibition of prolyl hydroxylase domain protein through attenuation of inflammation and extracellular matrix disruption. Clinical Science. 126(9). 671–678. 26 indexed citations
9.
Ikeda, Jiro, et al.. (2012). Peroxisome Proliferator-activated Receptor γ Agonists Attenuate Palmitate-induced Endoplasmic Reticulum Stress through Up-regulation of Stearoyl-CoA Desaturase 1. Circulation. 76. 11. 4 indexed citations
10.
Ichiki, Toshihiro, Kotaro Takeda, Hirohide Matsuura, et al.. (2012). Beraprost sodium, a stable prostacyclin analogue, improves insulin resistance in high-fat diet-induced obese mice. Journal of Endocrinology. 213(3). 285–291. 17 indexed citations
11.
Miyazaki, Ryohei, Toshihiro Ichiki, Toru Hashimoto, et al.. (2012). Acetylcholinesterase inhibitors attenuate angiogenesis. Clinical Science. 123(4). 241–249. 10 indexed citations
12.
Hashimoto, Toru, Toshihiro Ichiki, Jiro Ikeda, et al.. (2011). Inhibition of MDM2 attenuates neointimal hyperplasia via suppression of vascular proliferation and inflammation. Cardiovascular Research. 91(4). 711–719. 35 indexed citations
13.
Matsuura, Hirohide, Toshihiro Ichiki, Jiro Ikeda, et al.. (2011). Inhibition of Prolyl Hydroxylase Domain-Containing Protein Downregulates Vascular Angiotensin II Type 1 Receptor. Hypertension. 58(3). 386–393. 21 indexed citations
14.
Takeda, Kotaro, Toshihiro Ichiki, Keita Inanaga, et al.. (2009). Inhibition of Prolyl Hydroxylase Domain-Containing Protein Suppressed Lipopolysaccharide-Induced TNF-α Expression. Arteriosclerosis Thrombosis and Vascular Biology. 29(12). 2132–2137. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026